Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
478
-
Total 13F shares, excl. options
-
92.3M
-
Shares change
-
+1.45M
-
Total reported value, excl. options
-
$10.6B
-
Value change
-
+$169M
-
Put/Call ratio
-
0.92
-
Number of buys
-
227
-
Number of sells
-
-198
-
Price
-
$115.34
Significant Holders of RESMED INC - COM (RMD) as of Q3 2018
529 filings reported holding RMD - RESMED INC - COM as of Q3 2018.
RESMED INC - COM (RMD) has 478 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 92.3M shares
.
Largest 10 shareholders include Vanguard Group Inc (14.6M shares), BlackRock Inc. (11.2M shares), FMR LLC (7.87M shares), Capital World Investors (7.02M shares), STATE STREET CORP (5.97M shares), BAILLIE GIFFORD & CO (4.84M shares), DEUTSCHE BANK AG\ (1.89M shares), GEODE CAPITAL MANAGEMENT, LLC (1.89M shares), Bank of New York Mellon Corp (1.63M shares), and NORTHERN TRUST CORP (1.62M shares).
This table shows the top 478 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.